Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-4.70M
↑ 40% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-7.88M
Historical baseline
PeriodValueYoY Change
TTM$-4.70M-17.9%
2024$-3.99M+79.1%
2023$-19.04M-47.5%
2022$-12.91M-32.7%
2021$-9.73M-187.2%
2020$-3.39M-144.7%
2019$-1.39M-